Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
|---|---|---|---|---|
| Total revenue | -3.31%17.69M | 66.92%18.29M | 40.55%10.96M | 7.8M |
| Cost of revenue | -10.22%6.14M | 83.80%6.83M | -5.78%3.72M | 3.95M |
| Gross profit | 0.81%11.55M | 58.25%11.46M | 87.99%7.24M | 3.85M |
| Operating expense | 84.51%6.72M | -3.11%3.64M | 9.70%3.76M | 3.42M |
| Selling and administrative expenses | 84.51%6.72M | -3.11%3.64M | 9.70%3.76M | --3.42M |
| -General and administrative expense | 84.51%6.72M | -3.11%3.64M | 9.70%3.76M | --3.42M |
| Operating profit | -38.14%4.84M | 124.38%7.82M | 714.70%3.49M | 427.83K |
| Net non-operating interest income (expenses) | -10.19%-1.83M | -30.80%-1.66M | -160.64%-1.27M | -486.61K |
| Non-operating interest expense | 10.19%1.83M | 30.80%1.66M | 160.64%1.27M | --486.61K |
| Net investment income | ||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||
| Income from associates and other participating interests | ||||
| Special income (charges) | -11.11K | 0 | ||
| Less:Write off | ---- | --11.11K | --0 | ---- |
| Other non-operating income (expenses) | -67.46%-1.97M | -120.01%-1.18M | -160.28%-534.97K | -205.54K |
| Income before tax | -79.16%1.04M | 196.33%4.99M | 736.46%1.68M | -264.32K |
| Income tax | -6.65%1.67M | 164.69%1.79M | 154.67%676.25K | 265.54K |
| Net income | -119.78%-632K | 217.60%3.2M | 289.86%1.01M | -529.86K |
| Net income continuous operations | -119.78%-632K | 217.60%3.2M | 289.86%1.01M | ---529.86K |
| Noncontrolling interests | -92.76%-719K | -198.26%-373K | -7.70%-125.06K | -116.12K |
| Net income attributable to the company | -97.56%87K | 215.46%3.57M | 373.37%1.13M | -413.74K |
| Preferred stock dividends | ||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -97.56%87K | 215.46%3.57M | 373.37%1.13M | -413.74K |
| Gross dividend payment | ||||
| Basic earnings per share | -97.25%0.0003 | 202.78%0.0109 | 372.31%0.0036 | -0.0013 |
| Diluted earnings per share | -97.25%0.0003 | 202.78%0.0109 | 372.31%0.0036 | -0.0013 |
| Dividend per share | ||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.